NVZMY - Novozymes A/S

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 511.51B
Enterprise Value 311.52B
Trailing P/E 23.85
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)6.82
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Trading Information

Stock Price History

Beta (3Y Monthly) 0.44
52-Week Change 3-25.62%
S&P500 52-Week Change 30.90%
52 Week High 355.84
52 Week Low 340.38
50-Day Moving Average 344.95
200-Day Moving Average 346.15

Share Statistics

Avg Vol (3 month) 314.99k
Avg Vol (10 day) 324.79k
Shares Outstanding 5284.44M
Float 209.15M
% Held by Insiders 10.00%
% Held by Institutions 10.26%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.76
Forward Annual Dividend Yield 41.87%
Trailing Annual Dividend Rate 30.70
Trailing Annual Dividend Yield 31.73%
5 Year Average Dividend Yield 41.24
Payout Ratio 444.55%
Dividend Date 3Mar 19, 2019
Ex-Dividend Date 4Feb 28, 2019
Last Split Factor (new per old) 21/5
Last Split Date 3Dec 9, 2011

Financial Highlights

Currency in DKK.

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 22.63%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)12.79%
Return on Equity (ttm)29.79%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)-1.10%
Gross Profit (ttm)8.3B
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)1.69
Quarterly Earnings Growth (yoy)15.70%

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)42.19
Current Ratio (mrq)1.27
Book Value Per Share (mrq)5.93

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A